Clinical Trials Directory

Trials / Conditions / Cholangitis, Sclerosing

Cholangitis, Sclerosing

12 registered clinical trials studyying Cholangitis, Sclerosing — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions
NCT06864195
Imperial College London—
RecruitingPrimary Sclerosing Cholangitis in Children
NCT04181138
Arbor Research Collaborative for Health—
WithdrawnA Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)
NCT03678480
HighTide Biopharma Pty LtdPhase 2
Active Not RecruitingSelected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH
NCT02997878
University of BirminghamPhase 1 / Phase 2
TerminatedAn Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis
NCT03359174
Yale UniversityPhase 2
RecruitingSwiss Primary Sclerosing Cholangitis Cohort Study
NCT03146936
Fondazione Epatocentro Ticino—
CompletedDigital SpyGlass Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy
NCT02967926
Chulalongkorn UniversityPhase 3
CompletedCombination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Prima
NCT01456468
Yale UniversityPhase 1
CompletedCompare Conventional Colonosocpy to Endoscopic AFI, NBI for Dysplasia Detection for Ulcerative Colitis & Chola
NCT00587236
Mayo Clinic—
UnknownDifferential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
NCT00160940
University Health Network, Toronto—
CompletedPilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
NCT00004842
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 1
CompletedPhase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangi
NCT00004762
National Center for Research Resources (NCRR)Phase 2